Home
Browse
Search
Statistics
About
Usage
PMID: 24517344
Raju SV, Tate JH, Peacock SK, Fang P, Oster RA, Dransfield MT, Rowe SM
Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis.
Respir Res. 2014 Feb 11;15:18. doi: 10.1186/1465-9921-15-18.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
81
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24517344:81:407
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24517344:81:259
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 24517344:81:314
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 24517344:81:413
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 24517344:81:349
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 24517344:81:288
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 24517344:81:320
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Gly314Glu
X
ABCC7 p.Gly314Glu 24517344:81:369
status:
NEW
view ABCC7 p.Gly314Glu details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 24517344:81:429
status:
NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 24517344:81:435
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24517344:81:375
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24517344:81:472
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 24517344:81:543
status:
NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 24517344:81:781
status:
NEW
view ABCC7 p.Pro205Ser details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 24517344:81:827
status:
NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Gln493*
X
ABCC7 p.Gln493* 24517344:81:655
status:
NEW
view ABCC7 p.Gln493* details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 24517344:81:517
status:
NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 24517344:81:758
status:
NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 24517344:81:283
status:
NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 24517344:81:729
status:
NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Tyr122*
X
ABCC7 p.Tyr122* 24517344:81:308
status:
NEW
view ABCC7 p.Tyr122* details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 24517344:81:381
status:
NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Arg1158*
X
ABCC7 p.Arg1158* 24517344:81:640
status:
NEW
view ABCC7 p.Arg1158* details
ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 24517344:81:936
status:
NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 24517344:81:503
status:
NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 24517344:81:842
status:
NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 24517344:81:881
status:
NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.His199Tyr
X
ABCC7 p.His199Tyr 24517344:81:744
status:
NEW
view ABCC7 p.His199Tyr details
ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 24517344:81:550
status:
NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gln552*
X
ABCC7 p.Gln552* 24517344:81:723
status:
NEW
view ABCC7 p.Gln552* details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 24517344:81:896
status:
NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Lys710*
X
ABCC7 p.Lys710* 24517344:81:455
status:
NEW
view ABCC7 p.Lys710* details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 24517344:81:866
status:
NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Arg764*
X
ABCC7 p.Arg764* 24517344:81:634
status:
NEW
view ABCC7 p.Arg764* details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 24517344:81:277
status:
NEW
view ABCC7 p.Arg117Cys details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 24517344:81:510
status:
NEW
view ABCC7 p.Trp1089* details
ABCC7 p.Ile506Thr
X
ABCC7 p.Ile506Thr 24517344:81:684
status:
NEW
view ABCC7 p.Ile506Thr details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 24517344:81:497
status:
NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Ser1196*
X
ABCC7 p.Ser1196* 24517344:81:529
status:
NEW
view ABCC7 p.Ser1196* details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 24517344:81:492
status:
NEW
view ABCC7 p.Glu60* details
ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 24517344:81:335
status:
NEW
view ABCC7 p.Gly178Arg details
ABCC7 p.Gln1238*
X
ABCC7 p.Gln1238* 24517344:81:536
status:
NEW
view ABCC7 p.Gln1238* details
ABCC7 p.Gly330*
X
ABCC7 p.Gly330* 24517344:81:401
status:
NEW
view ABCC7 p.Gly330* details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 24517344:81:523
status:
NEW
view ABCC7 p.Ala559Thr details
ABCC7 p.Gln98Arg
X
ABCC7 p.Gln98Arg 24517344:81:718
status:
NEW
view ABCC7 p.Gln98Arg details
ABCC7 p.Arg709*
X
ABCC7 p.Arg709* 24517344:81:628
status:
NEW
view ABCC7 p.Arg709* details
ABCC7 p.Trp1098*
X
ABCC7 p.Trp1098* 24517344:81:953
status:
NEW
view ABCC7 p.Trp1098* details
ABCC7 p.Val520Ile
X
ABCC7 p.Val520Ile 24517344:81:903
status:
NEW
view ABCC7 p.Val520Ile details
As expected based on genotype-phenotype correlations in the disease [33], HBE cells derived from a F508del CFTR heterozygote had slightly lower CFTR activity at baseline than wild type monolayers as measured by Table 1 List of CFTR mutations analyzed F508del
R117H
1717-1G > A
R117C
G85E
R334W
1898 + 1G > A
Y122X
A455E
R347P
2184delA
G178R
I507del
R553X
2789 + 5G > A
G314E
G542X
R560T
3120 + 1G > A
G330X
G551D
W1282X
3659delC
R347H
N1303K
621 + 1G > T
K710X
406-1G > A
R1162X
711 + 1G > T
E60X
G480C
R1066C
W1089X
V520F
A559T
S1196X
Q1238X
S1251N
S1255X
663delT 935delA 1161delC 1288insTA 2184insA 2307insA 2711delT 2869insG
R709X
R764X
R1158X
574delA
Q493X
1898 + 5G > T 3905insT
I506T
3849 + 10kbC > T 712-1G > T
Q98R
Q552X
S549N
1078delT
H199Y
444delA
S549R
(T > G) 2143delT
P205S
2043delG 1811 + 1.6kbA > G 3272-26A > G
L206W
3791delC
Y1092X
(C > G) 3199del6
F508C
2108delA
Y1092X
(C > A)
D1152H
V520I
3667del4 394delTT 3876delA
M1101K
1677delTA
W1098X
(TGA) 1812-1G > A 4016insT 1609delCA 3171delC response to forskolin stimulation (49.3 &#b1; 11.5 bc;A/cm2 in CFTR (+/+) vs. 40.5 &#b1; 5.3 bc;A/cm2 in CFTR (+/-), although this was not statistically significant (Figure 1A,B).
Login to comment
135
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 24517344:135:72
status:
NEW
view ABCC7 p.Arg75Gln details
Similarly, we did not observe any increase in the incidence of M470V or
R75Q
as reported earlier in COPD patients from Serbia [22,23].
Login to comment
210
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 24517344:210:156
status:
NEW
view ABCC7 p.Arg75Gln details
Divac A, Nikolic A, Mitic-Milikic M, Nagorni-Obradovic L, Petrovic-Stanojevic N, Dopudja-Pantic V, Nadaskic R, Savic A, Radojkovic D: High frequency of the
R75Q
CFTR variation in patients with chronic obstructive pulmonary disease.
Login to comment